Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
Header
News Archive
Showing 1811 results
January 2015
-
Media Release
Sandoz biosimilar filgrastim recommended for approval by FDA Oncologic Drugs Advisory Committee
Oncologic Drugs Advisory Committee (ODAC) votes in favor of recommending biosimilar filgrastim for approval in the US Biosimilar filgrastim recommended to be approved for use in all requested… -
Media Release
Novartis collaborates with Intellia Therapeutics and Caribou Biosciences to explore making medicines and drug discovery tools with CRISPR genome editing technology
Collaborations give Novartis access to novel CRISPR technology platforms for the discovery and development of new medicines Intellia Therapeutics collaboration to explore therapeutic options for… -
Story From Our Labs
Can we edit our genes to fight disease?
-
Story From Our Labs
Rebuilding blood
Why are some sickle cell disease patients protected from the disease? Learn about our biomedical research in the field.
December 2014
-
Story Access to Healthcare
Talking to: Juergen Brokatzky-Geiger, Global Head of Corporate Responsibility at Novartis
In October 2013, we created a new, full-time position to lead our CR efforts. Juergen Brokatzky-Geiger, formerly Global Head of Human Resources and a member of the Executive Committee, took on this role effective in February 2014.
-
Story Discovery
A fresh look at fighting glaucoma
Ask Alan Frohman how he found out that he had glaucoma, and he'll quickly tell you that there were no warning signs.
October 2014
-
Story Access to Healthcare
Treating cataracts, a leading cause of preventable blindness worldwide
Cataracts are a serious but common eye condition affecting more than 20 million worldwide. A patient in Brazil tells her story.
-
Story Discovery
Biological battle of the bulge
John Hadcock’s wife Laura gave him an ultimatum: Run the energy out of Sunny, the new puppy, or take her back to the breeder. So Hadcock started running. On his first trip out, he had to stop half a mile in.
-
Story From Our Labs
10 big questions to dissect science papers
Novartis supports promising young scientists who want to improve their chances to attain advanced science degrees.
September 2014
-
Story Patient Perspectives
No longer living in fear
This moving personal story about the challenges of living with a rare disease is written by Rocco Falchetto, a biochemist and director of analytical sciences and imaging at the Novartis Institutes for BioMedical Research (NIBR).
-
Story From Our Labs
3-D printing: Scientists reinvent research tools
The word “biopsy” typically conjures images of large needles. Lab technicians—and scientists working to discover new medicines—need enough tissue from a patient to prepare and evaluate a sample.